gw003
Recombinant proteinexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2013 (NCT02156388)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Granulocyte colony-stimulating factorSupplementation
CSF3 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- gw003
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02725606 | Phase 1 | Mar 1, 2016 | Jiangsu T-Mab Biopharma Co.,Ltd |
| NCT02643901 | Phase 1 | Sep 1, 2015 | Jiangsu T-Mab Biopharma Co.,Ltd, Tianjin Medical University |
| NCT02156388 | Phase 1 | Aug 1, 2013 | Jiangsu T-Mab Biopharma Co.,Ltd, Tianjin Medical University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu T-Mab Biopharma Co.,Ltd | For profit | 3 | 3 | 1 | 2013 |
| Tianjin Medical University | Academic/Hospital | 2 | 0 | 1 | 2013 |
2 organizations
Page 1 / 1